The discovery of the autocrine anabolic effects of irisin on muscle paved the way for considering this molecule as a candidate for monitoring or potential treatment of muscle atrophy [17,18,19,20,21,22,23,24]. The gene discussed is FNDC5; the disease is muscle atrophy.